{"id":123776,"date":"2026-09-01T14:28:12","date_gmt":"2026-09-01T14:28:12","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/123776\/"},"modified":"2026-09-01T14:28:12","modified_gmt":"2026-09-01T14:28:12","slug":"novartis-gsk-mrna-bms-migraines-readout-newsletter","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/123776\/","title":{"rendered":"Novartis, GSK, mRNA, BMS, migraines: Readout Newsletter"},"content":{"rendered":"<p>\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/09\/GettyImages-1244346483-645x645.jpg\" alt=\"\" width=\"645\" height=\"645\" style=\"\"\/><\/p>\n<p>\t\t\t\tGABRIEL MONNET\/AFP via Getty Images<\/p>\n<p>\t\t\t\t\t<img decoding=\"async\" width=\"80\" height=\"80\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/09\/elaine-chen-avatar-round-80x80.png\" class=\"author-img-thumbnail\" alt=\"\" loading=\"eager\"  \/><img decoding=\"async\" width=\"80\" height=\"80\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/09\/helen-b-avatar-small2-80x80.png\" class=\"author-img-thumbnail\" alt=\"\" loading=\"eager\"  \/>\t\t\t\t<\/p>\n<p class=\"author-bio\">Elaine\u2019s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes <a href=\"https:\/\/www.statnews.com\/signup\/readout\/\" rel=\"nofollow noopener\" target=\"_blank\">The Readout newsletter<\/a>, and co-hosts STAT\u2019s weekly biotech podcast, <a href=\"https:\/\/www.statnews.com\/category\/readout-loud\/\" rel=\"nofollow noopener\" target=\"_blank\">The Readout Loud<\/a>. You can reach Elaine on Signal at elaineywchen.70.<\/p>\n<p class=\"author-bio\">Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on <a href=\"https:\/\/scicomm.xyz\/@HelenBranswell\" rel=\"nofollow noopener\" target=\"_blank\">Mastodon<\/a> and <a href=\"https:\/\/bsky.app\/profile\/helenbranswell.bsky.social\" rel=\"nofollow noopener\" target=\"_blank\">Bluesky<\/a>. You can reach Helen on Signal at hbranswell.01.<\/p>\n<p class=\"wp-block-paragraph\">Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\" rel=\"nofollow noopener\" target=\"_blank\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/p>\n<p class=\"wp-block-paragraph\">Good morning. I know this week probably feels extra long as we approach Labor Day weekend, but we will get through it together.<\/p>\n<p>The need-to-know this morning<\/p>\n<p>Trump strikes more drug pricing deals with biotechs<\/p>\n<p class=\"wp-block-paragraph\">President Trump yesterday announced that his administration has made deals with nine new companies, joining the 17 that it previously struck agreements with.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/09\/1788272891_444_stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n<p>\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"80\" height=\"80\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/09\/elaine-chen-avatar-round-80x80.png\" class=\"avatar-thumbnail\" alt=\"\" loading=\"lazy\"  \/>\t\t\t\t\t\t\t<\/p>\n<p class=\"author-title\">National Biotech Reporter<\/p>\n<p>\t\t\t\t\t\t\t<a class=\"social-item-icon twitter\" title=\"X\" href=\"https:\/\/x.com\/elaineywchen\" target=\"_blank\" rel=\"noopener nofollow\"><br \/>\n\t\t\t\t\t\t\t\t<a class=\"social-item-icon bluesky\" title=\"Bluesky\" href=\"https:\/\/bsky.app\/profile\/elaineywchen.bsky.social\" target=\"_blank\" rel=\"noopener nofollow\"><br \/>\n\t\t\t\t\t\t\t\t<a class=\"social-item-icon email\" title=\"Email\" href=\"http:\/\/www.statnews.com\/cdn-cgi\/l\/email-protection#8feae3eee6e1eaa1ece7eae1cffcfbeefbe1eaf8fca1ece0e2\" target=\"_blank\" rel=\"noopener nofollow\"><br \/>\n\t\t\t\t\t\t\t\t<a class=\"social-item-icon linkedin\" title=\"Linkedin\" href=\"https:\/\/www.linkedin.com\/in\/elaineywchen\/\" target=\"_blank\" rel=\"noopener nofollow\"><\/p>\n<p class=\"author-bio\">Elaine\u2019s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes <a href=\"https:\/\/www.statnews.com\/signup\/readout\/\" rel=\"nofollow noopener\" target=\"_blank\">The Readout newsletter<\/a>, and co-hosts STAT\u2019s weekly biotech podcast, <a href=\"https:\/\/www.statnews.com\/category\/readout-loud\/\" rel=\"nofollow noopener\" target=\"_blank\">The Readout Loud<\/a>. You can reach Elaine on Signal at elaineywchen.70.<\/p>\n<p>\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"80\" height=\"80\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/09\/helen-b-avatar-small2-80x80.png\" class=\"avatar-thumbnail\" alt=\"\" loading=\"lazy\"  \/>\t\t\t\t\t\t\t<\/p>\n<p class=\"author-title\">Infectious Diseases Correspondent<\/p>\n<p>\t\t\t\t\t\t\t<a class=\"social-item-icon twitter\" title=\"X\" href=\"https:\/\/x.com\/HelenBranswell\" target=\"_blank\" rel=\"noopener nofollow\"><br \/>\n\t\t\t\t\t\t\t\t<a class=\"social-item-icon bluesky\" title=\"Bluesky\" href=\"https:\/\/bsky.app\/profile\/helenbranswell.bsky.social\" target=\"_blank\" rel=\"noopener nofollow\"><br \/>\n\t\t\t\t\t\t\t\t<a class=\"social-item-icon linkedin\" title=\"Linkedin\" href=\"https:\/\/www.linkedin.com\/in\/helen-branswell-22ab936\/\" target=\"_blank\" rel=\"noopener nofollow\"><\/p>\n<p class=\"author-bio\">Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on <a href=\"https:\/\/scicomm.xyz\/@HelenBranswell\" rel=\"nofollow noopener\" target=\"_blank\">Mastodon<\/a> and <a href=\"https:\/\/bsky.app\/profile\/helenbranswell.bsky.social\" rel=\"nofollow noopener\" target=\"_blank\">Bluesky<\/a>. You can reach Helen on Signal at hbranswell.01.<\/p>\n","protected":false},"excerpt":{"rendered":"GABRIEL MONNET\/AFP via Getty Images Elaine\u2019s stories explore the boom in new obesity treatments, new drug payment models,&hellip;\n","protected":false},"author":2,"featured_media":123777,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[336,324,1000,206,338],"class_list":["post-123776","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-biotechnology","tag-drug-development","tag-drug-prices","tag-novartis","tag-research"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117196260098899671","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/123776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=123776"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/123776\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/123777"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=123776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=123776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=123776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}